25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ASTRAZENECA PHARMA INDIA LTD.
Buy, Hold or Sell?

Let's analyze Astrazeneca together

I guess you are interested in ASTRAZENECA PHARMA INDIA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ASTRAZENECA PHARMA INDIA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ASTRAZENECA PHARMA INDIA LTD.

I send you an email if I find something interesting about ASTRAZENECA PHARMA INDIA LTD..

Quick analysis of Astrazeneca (30 sec.)










What can you expect buying and holding a share of Astrazeneca? (30 sec.)

How much money do you get?

How much money do you get?
INR0.77
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR284.77
Expected worth in 1 year
INR481.93
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR261.16
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
INR6,349.65
Expected price per share
INR5,535 - INR7,093
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Astrazeneca (5 min.)




Live pricePrice per Share (EOD)

INR6,349.65

Intrinsic Value Per Share

INR-239.02 - INR155.21

Total Value Per Share

INR45.74 - INR439.98

2. Growth of Astrazeneca (5 min.)




Is Astrazeneca growing?

Current yearPrevious yearGrowGrow %
How rich?$85.4m$70.6m$14.7m17.3%

How much money is Astrazeneca making?

Current yearPrevious yearGrowGrow %
Making money$19.3m$11.9m$7.4m38.5%
Net Profit Margin12.5%9.9%--

How much money comes from the company's main activities?

3. Financial Health of Astrazeneca (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Astrazeneca? (5 min.)

Welcome investor! Astrazeneca's management wants to use your money to grow the business. In return you get a share of Astrazeneca.

What can you expect buying and holding a share of Astrazeneca?

First you should know what it really means to hold a share of Astrazeneca. And how you can make/lose money.

Speculation

The Price per Share of Astrazeneca is INR6,350. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Astrazeneca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Astrazeneca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR284.77. Based on the TTM, the Book Value Change Per Share is INR49.29 per quarter. Based on the YOY, the Book Value Change Per Share is INR30.92 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR16.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Astrazeneca.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.780.0%0.780.0%0.480.0%0.470.0%0.350.0%
Usd Book Value Change Per Share0.590.0%0.590.0%0.370.0%0.390.0%0.430.0%
Usd Dividend Per Share0.190.0%0.190.0%0.100.0%0.070.0%0.050.0%
Usd Total Gains Per Share0.780.0%0.780.0%0.470.0%0.460.0%0.480.0%
Usd Price Per Share66.24-66.24-39.51-45.98-34.05-
Price to Earnings Ratio85.44-85.44-82.90-101.76-100.40-
Price-to-Total Gains Ratio84.54-84.54-84.60-103.29-87.59-
Price to Book Ratio19.38-19.38-13.98-18.37-15.76-
Price-to-Total Gains Ratio84.54-84.54-84.60-103.29-87.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share76.1957988
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.190.07
Usd Book Value Change Per Share0.590.39
Usd Total Gains Per Share0.780.46
Gains per Quarter (13 shares)10.196.04
Gains per Year (13 shares)40.7424.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110313142114
220627274138
33092113116262
440123154148286
55015419518103110
66018523622123134
77021527725144158
88024631829164182
99027735933185206
1010030840036205230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Astrazeneca

About ASTRAZENECA PHARMA INDIA LTD.

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Fundamental data was last updated by Penke on 2024-07-08 14:06:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of ASTRAZENECA PHARMA INDIA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Astrazeneca earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.5%¬†means that¬†₹0.12 for each ₹1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 12.5%. The company is making a huge profit. +2
  • The TTM is 12.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.5%TTM12.5%0.0%
TTM12.5%YOY9.9%+2.6%
TTM12.5%5Y10.0%+2.4%
5Y10.0%10Y8.2%+1.8%
1.1.2. Return on Assets

Shows how efficient Astrazeneca is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • 15.0% Return on Assets means that¬†Astrazeneca generated¬†₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 15.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.0%0.0%
TTM15.0%YOY10.1%+4.9%
TTM15.0%5Y10.9%+4.1%
5Y10.9%10Y9.3%+1.6%
1.1.3. Return on Equity

Shows how efficient Astrazeneca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • 22.7% Return on Equity means Astrazeneca generated ₹0.23¬†for each¬†₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 22.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 22.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ22.7%TTM22.7%0.0%
TTM22.7%YOY16.9%+5.8%
TTM22.7%5Y18.4%+4.3%
5Y18.4%10Y16.2%+2.2%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of ASTRAZENECA PHARMA INDIA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Astrazeneca is operating .

  • Measures how much profit Astrazeneca makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%¬†means the company generated ₹0.00 ¬†for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.8%-14.8%
TTM-5Y10.0%-10.0%
5Y10.0%10Y8.7%+1.3%
1.2.2. Operating Ratio

Measures how efficient Astrazeneca is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are ₹1.33 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 1.328. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.328. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.328TTM1.3280.000
TTM1.328YOY1.379-0.050
TTM1.3285Y1.326+0.002
5Y1.32610Y1.091+0.234
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Astrazeneca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.61¬†means the company has ₹2.61 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 2.612. The company is able to pay all its short-term debts. +1
  • The TTM is 2.612. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.612TTM2.6120.000
TTM2.612YOY2.176+0.436
TTM2.6125Y2.121+0.491
5Y2.12110Y1.880+0.241
1.3.2. Quick Ratio

Measures if Astrazeneca is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.48¬†means the company can pay off ₹0.48 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.480. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.480. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.480TTM0.4800.000
TTM0.480YOY1.584-1.104
TTM0.4805Y1.334-0.855
5Y1.33410Y1.194+0.140
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Astrazeneca assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Astrazeneca to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.34¬†means that Astrazeneca assets are¬†financed with 34.0% credit (debt) and the remaining percentage (100% - 34.0%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.340. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.340. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.3400.000
TTM0.340YOY0.402-0.063
TTM0.3405Y0.408-0.068
5Y0.40810Y0.429-0.021
1.4.2. Debt to Equity Ratio

Measures if Astrazeneca is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 51.4% means that company has ₹0.51 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.514. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.514. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.5140.000
TTM0.514YOY0.673-0.159
TTM0.5145Y0.700-0.185
5Y0.70010Y0.762-0.062
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of ASTRAZENECA PHARMA INDIA LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every ₹1 in earnings Astrazeneca generates.

  • Above 15 is considered overpriced but¬†always compare¬†Astrazeneca to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 85.44 means the investor is paying ₹85.44¬†for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 98.288. Based on the earnings, the company is expensive. -2
  • The MRQ is 85.444. Based on the earnings, the company is expensive. -2
  • The TTM is 85.444. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD98.288MRQ85.444+12.845
MRQ85.444TTM85.4440.000
TTM85.444YOY82.898+2.546
TTM85.4445Y101.763-16.319
5Y101.76310Y100.401+1.361
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 928.442. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 807.109. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 807.109. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD928.442MRQ807.109+121.333
MRQ807.109TTM807.1090.000
TTM807.109YOY165.356+641.753
TTM807.1095Y253.216+553.893
5Y253.21610Y324.691-71.475
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Astrazeneca is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 19.38 means the investor is paying ₹19.38¬†for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 22.298. Based on the equity, the company is expensive. -2
  • The MRQ is 19.384. Based on the equity, the company is expensive. -2
  • The TTM is 19.384. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.298MRQ19.384+2.914
MRQ19.384TTM19.3840.000
TTM19.384YOY13.982+5.402
TTM19.3845Y18.369+1.015
5Y18.36910Y15.760+2.609
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ASTRAZENECA PHARMA INDIA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--49.29149.2910%30.920+59%32.889+50%35.596+38%
Book Value Per Share--284.767284.7670%235.476+21%210.609+35%170.160+67%
Current Ratio--2.6122.6120%2.176+20%2.121+23%1.880+39%
Debt To Asset Ratio--0.3400.3400%0.402-16%0.408-17%0.429-21%
Debt To Equity Ratio--0.5140.5140%0.673-24%0.700-27%0.762-33%
Dividend Per Share--16.00016.0000%8.000+100%5.800+176%4.000+300%
Eps--64.60264.6020%39.717+63%39.033+66%29.416+120%
Free Cash Flow Per Share--6.8396.8390%19.911-66%26.266-74%19.979-66%
Free Cash Flow To Equity Per Share--6.8396.8390%10.117-32%22.324-69%16.561-59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--155.209--------
Intrinsic Value_10Y_min---239.023--------
Intrinsic Value_1Y_max--24.010--------
Intrinsic Value_1Y_min--9.822--------
Intrinsic Value_3Y_max--65.696--------
Intrinsic Value_3Y_min--0.433--------
Intrinsic Value_5Y_max--99.611--------
Intrinsic Value_5Y_min---40.751--------
Market Cap158741247500.000+13%137996250000.000137996250000.0000%82311250000.000+68%95785750000.000+44%70934218750.000+95%
Net Profit Margin--0.1250.1250%0.099+26%0.100+24%0.082+52%
Operating Margin----0%0.148-100%0.100-100%0.087-100%
Operating Ratio--1.3281.3280%1.379-4%1.326+0%1.091+22%
Pb Ratio22.298+13%19.38419.3840%13.982+39%18.369+6%15.760+23%
Pe Ratio98.288+13%85.44485.4440%82.898+3%101.763-16%100.401-15%
Price Per Share6349.650+13%5519.8505519.8500%3292.450+68%3831.430+44%2837.369+95%
Price To Free Cash Flow Ratio928.442+13%807.109807.1090%165.356+388%253.216+219%324.691+149%
Price To Total Gains Ratio97.252+13%84.54284.5420%84.5950%103.287-18%87.591-3%
Quick Ratio--0.4800.4800%1.584-70%1.334-64%1.194-60%
Return On Assets--0.1500.1500%0.101+49%0.109+37%0.093+61%
Return On Equity--0.2270.2270%0.169+35%0.184+23%0.162+40%
Total Gains Per Share--65.29165.2910%38.920+68%38.689+69%39.596+65%
Usd Book Value--85430088.00085430088.0000%70642800.000+21%63182577.600+35%51048111.000+67%
Usd Book Value Change Per Share--0.5910.5910%0.371+59%0.395+50%0.427+38%
Usd Book Value Per Share--3.4173.4170%2.826+21%2.527+35%2.042+67%
Usd Dividend Per Share--0.1920.1920%0.096+100%0.070+176%0.048+300%
Usd Eps--0.7750.7750%0.477+63%0.468+66%0.353+120%
Usd Free Cash Flow--2051712.0002051712.0000%5973372.000-66%7879816.800-74%5993635.500-66%
Usd Free Cash Flow Per Share--0.0820.0820%0.239-66%0.315-74%0.240-66%
Usd Free Cash Flow To Equity Per Share--0.0820.0820%0.121-32%0.268-69%0.199-59%
Usd Market Cap1904894970.000+13%1655955000.0001655955000.0000%987735000.000+68%1149429000.000+44%851210625.000+95%
Usd Price Per Share76.196+13%66.23866.2380%39.509+68%45.977+44%34.048+95%
Usd Profit--19380672.00019380672.0000%11914800.000+63%11709734.400+66%8824734.000+120%
Usd Revenue--155463384.000155463384.0000%120356400.000+29%113987236.800+36%98976123.000+57%
Usd Total Gains Per Share--0.7830.7830%0.467+68%0.464+69%0.475+65%
 EOD+4 -4MRQTTM+0 -0YOY+23 -125Y+23 -1210Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1598.288
Price to Book Ratio (EOD)Between0-122.298
Net Profit Margin (MRQ)Greater than00.125
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.480
Current Ratio (MRQ)Greater than12.612
Debt to Asset Ratio (MRQ)Less than10.340
Debt to Equity Ratio (MRQ)Less than10.514
Return on Equity (MRQ)Greater than0.150.227
Return on Assets (MRQ)Greater than0.050.150
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.218
Ma 20Greater thanMa 506,556.095
Ma 50Greater thanMa 1006,219.349
Ma 100Greater thanMa 2005,753.086
OpenGreater thanClose6,630.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets10,780,283
Total Liabilities3,661,109
Total Stockholder Equity7,119,174
 As reported
Total Liabilities 3,661,109
Total Stockholder Equity+ 7,119,174
Total Assets = 10,780,283

Assets

Total Assets10,780,283
Total Current Assets9,327,064
Long-term Assets1,453,229
Total Current Assets
Cash And Cash Equivalents 5,055,687
Short-term Investments 181,508
Net Receivables 1,531,260
Inventory 2,278,820
Other Current Assets 278,530
Total Current Assets  (as reported)9,327,064
Total Current Assets  (calculated)9,325,805
+/- 1,259
Long-term Assets
Property Plant Equipment 648,420
Long-term Assets Other 17,494
Long-term Assets  (as reported)1,453,229
Long-term Assets  (calculated)665,914
+/- 787,315

Liabilities & Shareholders' Equity

Total Current Liabilities3,571,177
Long-term Liabilities89,932
Total Stockholder Equity7,119,174
Total Current Liabilities
Accounts payable 1,965,057
Other Current Liabilities 777,064
Total Current Liabilities  (as reported)3,571,177
Total Current Liabilities  (calculated)2,742,121
+/- 829,056
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt45,982
Long-term Liabilities  (as reported)89,932
Long-term Liabilities  (calculated)45,982
+/- 43,950
Total Stockholder Equity
Total Stockholder Equity (as reported)7,119,174
Total Stockholder Equity (calculated)0
+/- 7,119,174
Other
Capital Stock50,000
Common Stock Shares Outstanding 25,000
Net Invested Capital 7,119,174
Net Working Capital 5,755,887
Property Plant and Equipment Gross 648,420



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
4,154,900
4,605,400
5,618,000
7,063,600
7,747,100
8,565,600
9,848,700
10,780,283
10,780,2839,848,7008,565,6007,747,1007,063,6005,618,0004,605,4004,154,900
   > Total Current Assets 
2,515,500
3,209,200
4,047,200
5,423,200
6,187,600
7,056,700
8,354,891
9,327,064
9,327,0648,354,8917,056,7006,187,6005,423,2004,047,2003,209,2002,515,500
       Cash And Cash Equivalents 
1,132,300
1,094,500
1,683,600
818,000
30,100
88,200
25,000
5,055,687
5,055,68725,00088,20030,100818,0001,683,6001,094,5001,132,300
       Short-term Investments 
6,100
116,800
0
1,690,000
56,560
900
600
181,508
181,50860090056,5601,690,0000116,8006,100
       Net Receivables 
609,500
594,100
861,200
832,100
851,900
858,900
1,075,200
1,531,260
1,531,2601,075,200858,900851,900832,100861,200594,100609,500
       Inventory 
577,100
1,131,500
1,181,000
1,651,500
1,598,000
1,402,200
1,902,141
2,278,820
2,278,8201,902,1411,402,2001,598,0001,651,5001,181,0001,131,500577,100
       Other Current Assets 
109,200
157,500
198,800
208,100
71,100
80,500
371,952
278,530
278,530371,95280,50071,100208,100198,800157,500109,200
   > Long-term Assets 
0
0
1,570,800
1,640,400
1,559,500
1,508,900
1,493,961
1,453,229
1,453,2291,493,9611,508,9001,559,5001,640,4001,570,80000
       Property Plant Equipment 
916,500
790,300
817,300
960,100
849,800
766,900
701,940
648,420
648,420701,940766,900849,800960,100817,300790,300916,500
       Long-term Assets Other 
0
0
6,000
-1,158,400
20,135
29,903
30,927
17,494
17,49430,92729,90320,135-1,158,4006,00000
> Total Liabilities 
1,926,200
2,136,100
2,610,000
3,419,200
3,185,400
3,451,700
3,961,800
3,661,109
3,661,1093,961,8003,451,7003,185,4003,419,2002,610,0002,136,1001,926,200
   > Total Current Liabilities 
1,903,400
2,069,500
2,589,800
3,272,400
3,035,000
3,326,500
3,839,416
3,571,177
3,571,1773,839,4163,326,5003,035,0003,272,4002,589,8002,069,5001,903,400
       Accounts payable 
876,600
1,272,000
1,682,000
2,097,200
1,783,700
1,880,600
2,278,768
1,965,057
1,965,0572,278,7681,880,6001,783,7002,097,2001,682,0001,272,000876,600
       Other Current Liabilities 
300,900
229,500
219,200
282,400
479,600
626,500
1,525,423
777,064
777,0641,525,423626,500479,600282,400219,200229,500300,900
   > Long-term Liabilities 
0
0
20,200
146,800
150,400
125,200
122,553
89,932
89,932122,553125,200150,400146,80020,20000
       Long term Debt Total 
0
0
0
93,000
86,300
50,200
36,900
0
036,90050,20086,30093,000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
118,400
121,400
86,300
72,136
45,982
45,98272,13686,300121,400118,400000
> Total Stockholder Equity
2,228,700
2,469,300
3,008,000
3,644,400
4,561,700
5,113,900
5,886,900
7,119,174
7,119,1745,886,9005,113,9004,561,7003,644,4003,008,0002,469,3002,228,700
   Common Stock
50,000
50,000
50,000
50,000
50,000
50,000
50,000
0
050,00050,00050,00050,00050,00050,00050,000
   Retained Earnings 
1,438,700
1,675,000
2,213,500
2,855,000
3,772,300
4,320,900
5,811,200
0
05,811,2004,320,9003,772,3002,855,0002,213,5001,675,0001,438,700
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
740,000
744,300
744,500
739,400
739,400
743,000
5,836,883
0
05,836,883743,000739,400739,400744,500744,300740,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue12,955,282
Cost of Revenue-5,945,561
Gross Profit7,009,7217,009,721
 
Operating Income (+$)
Gross Profit7,009,721
Operating Expense-11,260,172
Operating Income1,695,110-4,250,451
 
Operating Expense (+$)
Research Development0
Selling General Administrative860,072
Selling And Marketing Expenses0
Operating Expense11,260,172860,072
 
Net Interest Income (+$)
Interest Income0
Interest Expense-12,007
Other Finance Cost-0
Net Interest Income-12,007
 
Pretax Income (+$)
Operating Income1,695,110
Net Interest Income-12,007
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,195,3801,695,110
EBIT - interestExpense = -12,007
1,615,056
1,627,063
Interest Expense12,007
Earnings Before Interest and Taxes (EBIT)02,207,387
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,195,380
Tax Provision-580,264
Net Income From Continuing Ops1,615,0561,615,116
Net Income1,615,056
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net012,007
 

Technical Analysis of Astrazeneca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Astrazeneca. The general trend of Astrazeneca is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Astrazeneca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ASTRAZENECA PHARMA INDIA LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6,911 < 7,093.

The bearish price targets are: 6,356 > 5,610 > 5,535.

Tweet this
ASTRAZENECA PHARMA INDIA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ASTRAZENECA PHARMA INDIA LTD.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ASTRAZENECA PHARMA INDIA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ASTRAZENECA PHARMA INDIA LTD.. The current macd is 97.21.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astrazeneca price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Astrazeneca. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Astrazeneca price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartASTRAZENECA PHARMA INDIA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ASTRAZENECA PHARMA INDIA LTD.. The current adx is 34.71.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Astrazeneca shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
ASTRAZENECA PHARMA INDIA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ASTRAZENECA PHARMA INDIA LTD.. The current sar is 7,484.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ASTRAZENECA PHARMA INDIA LTD.. The current rsi is 46.22. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Relative Strength Index (RSI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ASTRAZENECA PHARMA INDIA LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astrazeneca price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Stochastic Oscillator ChartASTRAZENECA PHARMA INDIA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ASTRAZENECA PHARMA INDIA LTD.. The current cci is -48.49295717.

ASTRAZENECA PHARMA INDIA LTD. Daily Commodity Channel Index (CCI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ASTRAZENECA PHARMA INDIA LTD.. The current cmo is -20.21901253.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Chande Momentum Oscillator (CMO) ChartASTRAZENECA PHARMA INDIA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ASTRAZENECA PHARMA INDIA LTD.. The current willr is -87.06075068.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ASTRAZENECA PHARMA INDIA LTD. Daily Williams %R ChartASTRAZENECA PHARMA INDIA LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of ASTRAZENECA PHARMA INDIA LTD..

ASTRAZENECA PHARMA INDIA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ASTRAZENECA PHARMA INDIA LTD.. The current atr is 275.82.

ASTRAZENECA PHARMA INDIA LTD. Daily Average True Range (ATR) ChartASTRAZENECA PHARMA INDIA LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ASTRAZENECA PHARMA INDIA LTD.. The current obv is 74,791.

ASTRAZENECA PHARMA INDIA LTD. Daily On-Balance Volume (OBV) ChartASTRAZENECA PHARMA INDIA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ASTRAZENECA PHARMA INDIA LTD.. The current mfi is 61.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ASTRAZENECA PHARMA INDIA LTD. Daily Money Flow Index (MFI) ChartASTRAZENECA PHARMA INDIA LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ASTRAZENECA PHARMA INDIA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

ASTRAZENECA PHARMA INDIA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.218
Ma 20Greater thanMa 506,556.095
Ma 50Greater thanMa 1006,219.349
Ma 100Greater thanMa 2005,753.086
OpenGreater thanClose6,630.500
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Astrazeneca with someone you think should read this too:
  • Are you bullish or bearish on Astrazeneca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Astrazeneca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ASTRAZENECA PHARMA INDIA LTD.

I send you an email if I find something interesting about ASTRAZENECA PHARMA INDIA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about ASTRAZENECA PHARMA INDIA LTD..

Receive notifications about ASTRAZENECA PHARMA INDIA LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.